February 2, 2022 Comments Off on New patent expiration for Gilead Sciences drug VEMLIDY Posted in: Uncategorized
Annual Drug Patent Expirations for VEMLIDY Vemlidy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are four…
The post New patent expiration for Gilead Sciences drug VEMLIDY appeared first o…
February 2, 2022 Comments Off on New patent expiration for Janssen Prods drug SYMTUZA Posted in: Uncategorized
Annual Drug Patent Expirations for SYMTUZA Symtuza is a drug marketed by Janssen Prods and is included in one NDA. It is available from one supplier. There are ten patents…
The post New patent expiration for Janssen Prods drug SYMTUZA appeared first on…
